Inventor
Francois BRUCELLE
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
C07DHeterocyclic compounds39%
A61KPreparations for medical, dental or toiletry purposes22%
PatentTitleYear
12,552,775Compounds and uses thereof202612,391,686Compounds and uses thereof202512,384,776Compounds and uses thereof202511,787,800BRD9 degraders and uses thereof202311,773,085Methods and compounds for treating disorders202311,547,695LSD1 inhibitors and medical uses thereof202311,274,090P300/CBP HAT inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to CONSTELLATION PHARMACEUTICALS INC (2)· patent assignee history
2022–2026Based in US· patent location history
2023–2026Patents assigned to FOGHORN THERAPEUTICS INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| FOGHORN THERAPEUTICS INC | 5 | 2023–2026 |
| CONSTELLATION PHARMACEUTICALS INC | 2 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2026 |